{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-241315","form_type":"8-K","ticker":"MDGL","cik":"0001157601","company_name":"MADRIGAL PHARMACEUTICALS, INC.","filed_at":"2023-09-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.248631+00:00","generated_at":"2026-06-10T09:08:47.441489+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Madrigal CCO Remy Sukhija departs; receives 12-month severance, bonus, option acceleration","bullets":["Chief Commercial Officer Remy Sukhija leaves to pursue other opportunities, effective immediately.","Separation includes 12 months base salary and 40% target bonus paid over 12 months.","Stock options for 28,500 shares accelerated, becoming exercisable immediately.","Medical benefit coverage continued for 12 months post-departure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-241315","json":"https://secwatch.observer/filing/0001193125-23-241315.json","markdown":"https://secwatch.observer/filing/0001193125-23-241315.md","text":"https://secwatch.observer/filing/0001193125-23-241315.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1157601/000119312523241315/0001193125-23-241315-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1157601/000119312523241315/d684437d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T09:08:47.441489+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d719ee028e","claim":"Remy Sukhija resigned as Chief Commercial Officer at MADRIGAL PHARMACEUTICALS, INC..","evidence_excerpt":"Madrigal Pharmaceuticals, Inc. (the “Company”) reports that Remy Sukhija, who has served as the Company’s Chief Commercial Officer since April of 2020, is leaving the Company to pursue other opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1157601/000119312523241315/0001193125-23-241315-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}